Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment and you're unlikely to be protected if something goes wrong. Take 2 mins to see our risk warning.
Access market-leading, predictable income from a defensive sector.
Our Pharmacy Income opportunity offers structured financing backed by NHS trade receivables.
Invest in our 3-year Wakala Note with an expected 10% annual profit, paid through periodic distributions.
This opportunity is designed to provide a secure, predictable income stream, complementing venture capital or private equity portfolios.
10% annually
£5,000
36 months
The Cur8 Pharmacy Income opportunity allows UK tax payers to invest up to £20,000 per year tax-free.
If you’re in the higher UK tax bracket, investing through our IF-ISA means your tax-free return is equivalent to a 16.7% returnoutside an ISA.
Cur8 Capital will make repayments in line with the agreed repayment schedule, ensuring a structured and predictable return for investors.
Invested in the Pharmacy Income Fund
Funding new pharmacy acquisitions, increasing availability of NHS-backed healthcare services across more locations.
Investing in automation, inventory optimisation, and cost-saving efficiencies to improve service delivery.
Implementing digital healthcare solutions, enabling high-margin services such as consultations, NHS-funded care, and private healthcare offerings.
Supporting the consolidation of independent pharmacies into a service-led, tech-enabled healthcare group, enhancing financial resilience and future value.